secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001493152-25-011419
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Processa Pharmaceuticals files prospectus supplement to sell up to $5.2 million shares of common stock
--------------------------------------------------------------------------------

- On July 25, 2025, Processa filed a prospectus supplement to its Form S-3 (Registration No. 333-279588) for an equity distribution agreement with A.G.P./Alliance Global Partners.
- The supplement permits the sale of $5,239,073 shares of common stock, with $1,546,338 shares already sold in the prior 12 months.
- As of the prospectus supplement date, $3,692,735 shares remain available for sale under the agreement.
- The offering is conducted via an at-the-market equity distribution agreement with A.G.P./Alliance Global Partners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225011419/0001493152-25-011419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315225011419/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer